ABIONYX PHARMA SA (ABNX.PA) Stock Cash Flow
EPA:ABNX • FR0012616852
Current stock price
3.6 EUR
-0.04 (-1.1%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.55M | -4.38M | -3.52M | -4.21M | -5.82M | |||
| Depreciation Amortization | 126.00K | 135.00K | 153.00K | 135.00K | 119.00K | |||
| Change In Working Capital | 1.60M | -28.00K | 538.00K | 97.00K | -1.74M | |||
| Taxes Paid | -9.00K | N/A | N/A | N/A | N/A | |||
| Other non cash items | 890.00K | 640.00K | -871.00K | 615.00K | 755.00K | |||
| OPERATING CASH FLOW | -2.93M | -3.63M | -3.70M | -3.36M | -6.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -242.00K | -76.00K | -130.00K | -175.00K | -166.00K | |||
| Other Investing Activity | 37.00K | N/A | N/A | -200.00K | 1.50M | |||
| INVESTING CASH FLOW | -205.00K | -76.00K | -130.00K | -175.00K | 1.34M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -429.00K | -490.00K | -300.00K | -236.00K | -19.00K | |||
| Stock Issued/Repurchased | 1.68M | 3.33M | 4.19M | 42.00K | 3.99M | |||
| Other Financing Activity | 2.17M | N/A | N/A | -200.00K | N/A | |||
| FINANCING CASH FLOW | 3.42M | 2.84M | 3.89M | -194.00K | 3.97M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 287.00K | -866.00K | 58.00K | -3.73M | -1.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.93M | -3.63M | -3.70M | -3.36M | -6.69M | |||
| Capital Expenditure | -242.00K | -76.00K | -130.00K | -175.00K | -166.00K | |||
| FREE CASH FLOW | -3.17M | -3.71M | -3.83M | -3.53M | -6.86M | |||
All data in EUR